Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Tan FionaChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $920K 8,000 sh | Oct 22, 2026 |
| 22 | Saba Capital Management, L.P.10% Owner | Open-market purchase | BUY | $30K 2,600 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 21 | Mathews Darrell Lee Jr.Executive Vice President | Open-market sale | SELL | $7,859 136 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 9, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 20 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Oct 22, 2026 traded Oct 1, 2026 |
| 19 | Neagle MatthewChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $563K 31.3K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 18 | Kiernan MichaelChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $127K 50.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 18 | Hyman JonathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $12.92M 285.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $1.29M 7,420 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Narayanadas VivekGeneral Counsel & Secretary | Open-market sale · 10b5-1 plan | SELL | $27K 1,021 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Chang Fred FachingDirector, 10% Owner | Open-market sale | SELL | $38K 3,582 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 17 | Chang Fred FachingDirector, 10% Owner | Open-market sale | SELL | $38K 3,582 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $1.08M 6,190 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 17 | Kneppers Chris JDirector | Open-market sale | SELL | $13K 125.5K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 15 | Dai KunDirector, Chief Executive Officer | Open-market purchase · 10b5-1 plan | BUY | $3,755 4,002 sh | Oct 22, 2026 traded Oct 21, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $261K 1,523 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $579K 3,300 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $6.52M 185.9K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $637K 3,690 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 13 | Wirth James FPresident & CEO, 10% Owner, Chairman | Open-market sale · 10b5-1 plan | SELL | $2.01B 43.1K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 12 | King Ryan ADirector, Co-Founder | Open-market sale · 10b5-1 plan | SELL | $351K 11.3K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $67K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $176K 1,000 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $98K 577 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $135K 800 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $67K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $98K 600 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $82K 500 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $113K 700 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 11 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $66K 400 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 10 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.25M 7,369 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 10 | Hyman JonathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $300K 10.0K sh | Oct 22, 2026 traded Oct 15, 2026 |
| 8 | Kuykendall AnneSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $41K 738 sh | Oct 22, 2026 traded Oct 22, 2026 |
| 7 | Sarowitz Steven IDirector, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $268K 1,589 sh | Oct 22, 2026 traded Oct 20, 2026 |
| 7 | Denier Anthony MichaelDirector, President | Open-market sale · 10b5-1 plan | SELL | $328K 53.8K sh | Oct 22, 2026 traded Oct 21, 2026 |
| 7 | O'Toole Brian EDirector, CEO and President | Open-market sale · 10b5-1 plan | SELL | $337K 20.0K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 7 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $501K 14.1K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 6 | Baig SaqibChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $55K 10.0K sh | Oct 22, 2026 traded Oct 20, 2026 |